Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester, Academic Health Science Center M6 8HD, UK.
Clin Exp Dermatol. 2011 Aug;36(6):585-9; quiz 588-9. doi: 10.1111/j.1365-2230.2011.04108.x. Epub 2011 Jul 1.
This review summarizes key clinical findings from 5 guidelines and 21 systematic reviews on psoriasis published or indexed in the period November 2009 to October 2010. The highlights include the British Association of Dermatologists guidelines on the use of biological interventions in psoriasis, and guidelines on the efficacy and use of acitretin. Biological therapies were reviewed for use in specific patient groups (such as those with hepatitis C) and from a health-economics perspective. Another systematic review focused on outcome measures used to assess the severity of psoriasis. Finally, comorbidities including cardiovascular risk were the topic of four systematic reviews.
这篇综述总结了 2009 年 11 月至 2010 年 10 月发表或索引的 5 项银屑病指南和 21 项系统评价的主要临床发现。重点包括英国皮肤病学家协会关于生物干预措施在银屑病中的应用指南，以及关于阿维 A 酯疗效和应用的指南。从特定患者群体（如丙型肝炎患者）和卫生经济学角度对生物疗法进行了审查。另一项系统评价则侧重于用于评估银屑病严重程度的结果测量。最后，包括心血管风险在内的共病是四项系统评价的主题。
